Article citationsMore>>

Di Roio, A., Hubert, M., Besson, L., Bossennec, M., Rodriguez, C., Grinberg-Bleyer, Y., et al. (2023) MDR1-Expressing CD4+ T Cells with Th1.17 Features Resist to Neoadjuvant Chemotherapy and Are Associated with Breast Cancer Clinical Response. Journal for ImmunoTherapy of Cancer, 11, e007733.
https://doi.org/10.1136/jitc-2023-007733

has been cited by the following article:

• TITLE: The Role of T Lymphocyte Subsets in Breast Cancer

  AUTHORS: Qian Li, Guanming Lu

  KEYWORDS: Breast Cancer, Tumor Microenvironment, T Lymphocytes, Immune Cells

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.12, December 12, 2024

  ABSTRACT: Breast cancer, a leading type of malignant tumor, is highly heterogeneous, with each subtype having different prognoses and potential therapeutic targets. The tumor microenvironment plays a key role in tumor development. It consists of immune cells, stromal cells, the extracellular matrix, and blood and lymphatic networks, forming a complex immune regulatory network. In anti-tumor immunity, the cellular immune response led by T lymphocytes is crucial. An in-depth study of T lymphocytes in the tumor microenvironment may offer new insights for breast cancer treatment. This article reviews the role of T lymphocyte subsets in the current tumor microenvironment of breast cancer.